Ben Conti

Ben Conti is a finance professional with extensive experience in the biotechnology and healthcare sectors. Currently serving as Director of Finance at Orchard Therapeutics since May 2020, Ben has progressed through various finance roles including Associate Director and Senior Manager of Finance Operations. Prior experience includes leadership positions at Sensyne Health from February 2019 to April 2020, where Ben held the titles of Head of Group Financial Reporting and Group Financial Reporting Manager. Prior to this, Ben worked at PwC from September 2013 to January 2019, advancing from Associate to Manager. Ben holds the ACA qualification from ICAEW (2013-2016) and a Master of Mathematics (MMath) in Mathematics from Durham University (2008-2012).